LCTX Lineage Cell Therapeutics, Inc.
$1.01▼ -0.98%
Healthcare
Other
After hours
$1.02▲ +0.98%
Sep 11, 7:59 PM ET
Volume 909.1K
Avg Volume (10D) 903.7K
Key Metrics & Fundamentals
Market Cap
$255.44M
P/E Ratio
–
Div Yield
–%
52W Range
1.00 - 2.09
% vs 50 MA
-10.43%
% vs 200 MA
-30.46%
RSI-14
36.2
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.45
Free Cash Flow
-$7.35M
Gross Rev
$1.07M
Gross Profit
$1.07M
EBITDA
-$18.84M
COGS
$0
Operating Exp
$9.99M
Operating Income
-$8.92M
EBIT
-$8.92M
Pretax Income
$1.54M
Net Income
$1.48M
EPS (Diluted)
0.01
Price & Volume History
Loading chart…
Recent News
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Business Wire · Sep 8, 2026 12:00 PM
Lineage Cell Therapeutics (LCTX) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 14, 2026 12:32 AM
Lineage Cell Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 9, 2026 7:04 PM
Lineage Cell Therapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 7, 2026 12:30 PM
Lineage Cell Therapeutics Inc (LCTX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended, ...
GuruFocus.com · Aug 7, 2026 5:12 AM
Lineage Cell (LCTX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 6, 2026 9:40 PM
Lineage Cell: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 8:42 PM
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Business Wire · Aug 6, 2026 8:01 PM
Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
Business Wire · Jul 30, 2026 12:00 PM
Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject’ Cell Therapy Plan
MarketBeat · Jul 14, 2026 7:02 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See LCTX's money flow as a full page
Social Sentiment
No Reddit posts found for LCTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.